Health Services Research
Latest posts by Health Services Research (see all)
- Sustained Reduction in Health Disparities Achieved through Targeted Quality Improvement:… - Mar. 19, 2015
- On the Hospital Volume and Outcome Relationship: Does Specialization Matter More Than Volume? - Mar. 18, 2015
- Measuring Prices in Health Care Markets Using Commercial Claims Data - Mar. 16, 2015
- Physical Therapy or Advanced Imaging as First Management Strategy Following a New Consultation… - Mar. 16, 2015
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.